- Home
- SRTS
as 08-29-2025 2:34pm EST
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
| Founded: | 2010 | Country: | United States |
| Employees: | N/A | City: | BOCA RATON |
| Market Cap: | 75.5M | IPO Year: | 2016 |
| Target Price: | $8.00 | AVG Volume (30 days): | 216.2K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.05 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.03 - $9.33 | Next Earning Date: | 08-07-2025 |
| Revenue: | $37,564,000 | Revenue Growth: | 3.29% |
| Revenue Growth (this year): | -15.93% | Revenue Growth (next year): | 33.38% |
Stock Insider Trading Activity of Sensus Healthcare Inc. (SRTS)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Sardano Michael | SRTS | PRESIDENT AND GENERAL COUNSEL | Aug 13 '25 | Buy | $3.37 | 1,000 | $3,370.00 | 116,839 |
Latest Sensus Healthcare Inc. News
SRTS Breaking Stock News: Dive into SRTS Ticker-Specific Updates for Smart Investing
Business Wire
2 months ago
Sensus Healthcare Engages Radiology Oncology Systems (ROS) as Primary Distribution Partner for its SRT Systems to Radiation Oncologists
Zacks
2 months ago
Sensus Healthcare, Inc. (SRTS) Stock Moves 1.91%: What You Should Know
Simply Wall St.
3 months ago
Investing in Sensus Healthcare (NASDAQ:SRTS) five years ago would have delivered you a 71% gain
Zacks
3 months ago
Is It Worth Investing in Sensus Healthcare (SRTS) Based on Wall Street's Bullish Views?
Simply Wall St.
3 months ago
Sensus Healthcare First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
GuruFocus.com
3 months ago
Sensus Healthcare Inc (SRTS) Q1 2025 Earnings Call Highlights: Navigating Challenges with ...
Zacks
3 months ago
Sensus Healthcare, Inc. (SRTS) Reports Q1 Loss, Tops Revenue Estimates
Business Wire
3 months ago
Sensus Healthcare Reports First Quarter 2025 Financial Results
Compare SRTS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SRTS Sensus Healthcare Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.